KYSOS 2026 Fall Opioid Summit

KYSOS 2026 Fall Opioid Summit

The Kentucky Statewide Opioid Stewardship (KYSOS) Opioid Summit will convene health care leaders from across the Commonwealth to highlight best practices and community partnerships to continue improving opioid stewardship efforts.   

Target Audience: CEOs, CNOs, CMOs, quality and clinical leaders, nurses, pharmacists, case management, emergency department staff, peer support specialists, and other health care professionals.

Fees and Registration 
Cost of Registration: $50.00 
Registration fee includes sessions and meals 

Register Now

Cancellation Policy 
Written notice of registration cancellation must be received more than 14 days prior to the event to be eligible for a refund, less a $50 cancellation fee. No refunds will be issued for cancellations received within 14 days of the event, including no-shows. Substitutions from the same organization are welcome at any time prior to the event. 

Continuing Education

The Kentucky Hospital Association is an approved provider of continuing nursing education by the Kentucky Board of Nursing (KBN). KBN approval of a continuing nursing education provider does not constitute endorsement of program content. This educational activity is offered for 6.3 contact hours, with offering number 5-0023-12-27-35, expiration date 12/31/2027. No partial credit will be given. To receive credit, participants must sign in to the event, attend the entire educational offering, provide their nursing license number, and complete the offering evaluation. After the conclusion of this event, a QR code link to an evaluation will be provided to attendees. Attendees will have a deadline of 11/05/2026 to complete the survey in order to receive the CEU certificate. Failure to complete any step in the process outlined above will result in non-issuance of CEU credit in accordance with KBN guidelines.  

KHA has also applied for pharmacy credits for this conference.

Agenda

8:00 – 8:50 a.m. 

Breakfast and Networking

8:50 – 9:00 a.m. 

Welcome 

Melanie Landrum 
Interim CEO/Senior Vice President, Data, Operations and Innovation 
Kentucky Hospital Association 

9:00 – 9:15 a.m. 

Keynote Address

Dr. Katherine Marks, Ph.D. 
Commissioner 
Department for Behavioral Health, Developmental & Intellectual Disabilities 
Cabinet for Health and Family Services

9:15 – 10:00 a.m. 

KASPER: Beyond the Basics

Jordan Shannon 
KASPER Epidemiologist 
Office of Inspector General – Drug Enforcement & Professional Practices Branch 
Kentucky Cabinet for Health & Family Services 

This session focuses on advanced tools and data interpretation, including Prescriber Report Cards, Reverse KASPER Reports, patient alerts, and overdose risk indicators such as high MME and overlapping prescriptions. It also highlights KASPER integration with electronic health records, interstate data sharing, and how quarterly trend reports and heat maps are used to identify prescribing hot spots across Kentucky. An important component is the inclusion of Narcotic Treatment Program data and how reporting improves care coordination while reducing stigma.   

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Identify key KASPER tools and features available to support clinical decision-making. 
  • Describe how patient and prescriber-based reports can be used to review controlled substance prescribing information. 
  • Explain how KASPER integration, interstate data sharing, and Narcotic Treatment Program data expand access to prescription information. 

10:00 – 11:00 a.m. 

From Stigma to Strength: A Trait-Based Approach to Peer Support and Recovery 

Dr. Jason Roop 
Founder & Executive Director 
The Center for Trait-Based Transformation 

This presentation introduces the Trait-Based Recovery Model and explores how peer support specialists and health care professionals can recognize strengths, challenge stigmatizing assumptions, and support the development of resilience, self-awareness, and a recovery-oriented identity. Participants will examine the model’s evidence and practical applications, with particular attention to peer engagement, hospital bridge programs, and ongoing recovery support.  

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Describe how stigma and assumptions about addiction can influence interactions in health care and peer support. 
  • Identify core traits within the Trait-Based Recovery Model and explain their relevance to recovery, including resilience, self-awareness, and emotional intelligence. 
  • Discuss published research findings and limitations relevant to the Trait-Based Recovery Model. 
  • Apply strengths-focused communication strategy to a health care or peer-support scenario that recognizes individual capacity and supports recovery-oriented goals. 

11:00 – 11:15 a.m. 

Networking Break

11:15 – 12:15 p.m. 

Buprenorphine and Methadone Initiation Strategies in the Emergency Department 

Dr. Jordan Woolum, PharmD, BCPS, DABAT 
Emergency Medicine Clinical Pharmacist 
UK HealthCare 

This session will explore current trends in prescribing medications for opioid use disorder (MOUD) from the emergency department and elaborate on the nuances of use cases for both buprenorphine and methadone.  

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Review therapies for MOUD. 
  • Highlight prescribing limitations mandated by federal and state law. 
  • Describe current trends in MOUD prescribing from the modern emergency department. 
  • Elaborate on strategies to initiate therapy from the emergency department. 

12:15 – 1:15 p.m. 

Lunch and Networking

1:15 – 2:00 p.m. 

Diversion in Health Care Settings 

Martin Redd 
Diversion Program Manager 
Drug Enforcement Administration – Louisville Field Division 

This session will explore the Diversion Control Division within the Drug Enforcement Administration and its regulatory responsibilities within health care settings. Attendees will also gain insight into outside influences that affect drug diversion.   

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Explain the role of the Diversion Control Division. 
  • Identify the signs of diversion. 
  • List regulatory requirements. 
  • Understand the dangers of illicit fentanyl and counterfeit pills. 

2:00 – 2:15 p.m. 

 Networking Break

2:15 – 3:15 p.m. 

Emerging Drugs and OUD 

Dr. Regan Baum, PharmD, BCCCP
UK HealthCare 

This session will review the evolving illicit drug supply and the clinical challenges posed by new substances and common adulterants. The speaker will discuss limitations of current hospital toxicology testing, recognize how emerging substances can alter clinical presentation and management, and review practical treatment strategies, including emerging antidotal therapies, to improve patient outcomes.  

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Understand the dynamic nature of the illicit drug supply in Kentucky, including common adulterants. 
  • Recall the common hospital testing modalities used for detection, while demonstrating an understanding of the limitations of the testing. 
  • Outline the appropriate treatment strategies for management and review emerging antidotal therapies for improved patient outcomes. 

3:15 – 4:00 p.m. 

KYSOS Outpatient Primary Care Panel 

Moderator:  
Shanna Jaggers, PharmD 
KYSOS Consultant 
Kentucky Hospital Association 

Panelists: 
La Shay Reed, RN 
Division Chief Nursing Officer for Ambulatory Services 
Appalachian Regional Healthcare 

Ashley Estes, MSN, RN 
Vice President of Clinical Operations
T. J. Regional Health

Melissa Slade, RN, BSN, CRHCP 
Primary Care/Rural Health Clinic Manager 
Harrison Memorial Hospital

This panel will discuss how Kentucky hospitals are putting outpatient opioid stewardship into practice through the KYSOS Outpatient Primary Care Program. Receive a walkthrough of the program’s purpose and implementation as participating hospitals share real-world experiences, lessons learned, and practical insights for integrating opioid stewardship into primary care settings.  

Objectives: At the conclusion of this offering, attendees will be able to: 

  • Define the Outpatient Primary Care Program and its purpose. 
  • Discuss the steps and timeline of the program. 
  • Discuss and share the experience of implementing the program into primary care clinics. 

4:00 p.m. 

Wrap Up 

Emily Henderson, PharmD, LDE 
KYSOS Consultant 
Kentucky Hospital Association